Organon (OGN) Other Working Capital Changes (2020 - 2026)

Organon (OGN) recorded quarterly Other Working Capital Changes of -$8.0 million in Q1 2026, up 20.0% quarter-over-quarter from -$10.0 million in Q4 2025, and down 172.73% on a YoY basis from $11.0 million in Q1 2025.

Organon (OGN) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Organon's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$8.0 million for Q1 2026.

  • In Q1 2026, Other Working Capital Changes fell 172.73% year-over-year to -$8.0 million; the TTM figure through Mar 2026 stood at -$158.0 million (down 4050.0% YoY), while the FY2025 annual figure was -$139.0 million, down 379.31% from the prior year.
  • Other Working Capital Changes was -$8.0 million for Q1 2026 at Organon, up from -$10.0 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $178.0 million in Q2 2024 to a low of -$223.0 million in Q3 2024.
  • Historically, Other Working Capital Changes has averaged -$11.5 million across 5 years, with a median of -$8.0 million in 2025.
  • Biggest YoY gain for Other Working Capital Changes was 584.62% in 2024; the steepest drop was 555.1% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $16.0 million in 2022, then slumped by 550.0% to -$72.0 million in 2023, then jumped by 152.78% to $38.0 million in 2024, then plunged by 126.32% to -$10.0 million in 2025, then gained by 20.0% to -$8.0 million in 2026.
  • The last three Other Working Capital Changes figures came in at -$8.0 million (Q1 2026), -$10.0 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,134,969.93 Bn 92,134,964.97 Bn 7.76 Bn
2 Eli Lilly 1,027.45 Bn 1,022.17 Bn 16.22 Bn
3 Johnson & Johnson 559.08 Bn 537.03 Bn 15.96 Bn
4 AbbVie 394.75 Bn 385.40 Bn 10.78 Bn
5 Merck 295.12 Bn 289.47 Bn 12.09 Bn
6 Amgen 186.65 Bn 174.61 Bn 5.87 Bn
7 Gilead Sciences 159.22 Bn 151.50 Bn 5.52 Bn
8 Pfizer 146.00 Bn 133.23 Bn -1.21 Bn
9 Bristol Myers Squibb 113.22 Bn 102.77 Bn 8.07 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -8.00 Mn
Mar 31, 2026 -8.00 Mn
Dec 31, 2025 -10.00 Mn
Dec 31, 2025 -10.00 Mn
Sep 30, 2025 -8.00 Mn
Sep 30, 2025 -8.00 Mn
Jun 30, 2025 -132.00 Mn
Jun 30, 2025 -132.00 Mn
Mar 31, 2025 11.00 Mn
Mar 31, 2025 11.00 Mn
Dec 31, 2024 38.00 Mn
Dec 31, 2024 38.00 Mn
Sep 30, 2024 -223.00 Mn
Sep 30, 2024 -223.00 Mn
Jun 30, 2024 178.00 Mn
Jun 30, 2024 178.00 Mn
Mar 31, 2024 -22.00 Mn
Mar 31, 2024 -22.00 Mn
Dec 31, 2023 -72.00 Mn
Dec 31, 2023 -72.00 Mn